Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Doloradix AB
AB
In liquidation
Org 5590963525
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 9 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Doloradix AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
-1M
-2M
-3M
-4M
2020: -1M
-1M
2020
2021: -2M (-100% vs 2020)
-2M
-100%
2021
2022: -3M (-50% vs 2021)
-3M
-50%
2022
2023: -3M (0% vs 2022)
-3M
0%
2023
2024: -2M (+33% vs 2023)
-2M
+33%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
20
0
24
49
Staff expenses
−1 154
—
−1 463
—
—
EBITDA
−2 099
−2 677
−2 821
−2 135
−839
Depreciation & amort.
—
−0
—
−0
−0
EBIT
−2 099
−2 677
−2 821
−2 135
−839
Net financials
−2
−5
−1
−1
—
Profit before tax
−425
−1 292
−1 626
−1 661
−839
Tax
—
−0
—
−0
−0
Net profit
−425
−1 292
−1 626
−1 661
−839
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
249
319
542
2 128
1 731
Equity
−380
45
140
1 766
819
Long-term debt
—
0
—
0
0
Short-term debt
629
273
403
362
912
Total debt
629
273
403
362
912
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
−152,8 %
This company
38,2 %
Market median
This company
Market median
500% below market
2020
2024
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Doloradix AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
